[HTML][HTML] eATP and autoimmune diabetes
C Loretelli, I Pastore, ME Lunati, A Abdelsalam… - Pharmacological …, 2023 - Elsevier
Purpose of review The purine nucleotide adenosine triphosphate (ATP) is released into
extracellular spaces as extracellular ATP (eATP) as a consequence of cell injury or death …
extracellular spaces as extracellular ATP (eATP) as a consequence of cell injury or death …
[HTML][HTML] miR-21 antagonism reprograms macrophage metabolism and abrogates chronic allograft vasculopathy
Despite much progress in improving graft outcome during cardiac transplantation, chronic
allograft vasculopathy (CAV) remains an impediment to long-term graft survival. MicroRNAs …
allograft vasculopathy (CAV) remains an impediment to long-term graft survival. MicroRNAs …
[HTML][HTML] Untangling local pro-inflammatory, reparative, and regulatory damage-associated molecular-patterns (DAMPs) pathways to improve transplant outcomes
GK Dwyer, HR Turnquist - Frontiers in Immunology, 2021 - frontiersin.org
Detrimental inflammatory responses after solid organ transplantation are initiated when
immune cells sense pathogen-associated molecular patterns (PAMPs) and certain damage …
immune cells sense pathogen-associated molecular patterns (PAMPs) and certain damage …
The P2X7 purinergic receptor: an emerging therapeutic target in cardiovascular diseases
Z Chen, L He, L Li, L Chen - Clinica Chimica Acta, 2018 - Elsevier
The P2X7 purinergic receptor, a calcium permeable cationic channel, is activated by
extracellular ATP. Most studies show that P2X7 receptor plays an important role in the …
extracellular ATP. Most studies show that P2X7 receptor plays an important role in the …
[HTML][HTML] P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes
Purinergic receptor-7 (P2X7R) signaling controls Th17 and Th1 generation/differentiation,
while NOD-like receptor P3 (NLRP3) acts as a Th2 transcriptional factor. Here, we …
while NOD-like receptor P3 (NLRP3) acts as a Th2 transcriptional factor. Here, we …
Cyclic guanosine monophosphate-adenosine monophosphate synthetase/stimulator of interferon genes signaling aggravated corneal allograft rejection through …
C Wei, Q Huang, F Zeng, L Ma, X Bai, X Zhu… - American Journal of …, 2024 - Elsevier
The activation of innate immunity following transplantation has been identified as a crucial
factor in allograft inflammation and rejection. However, the role of cyclic guanosine …
factor in allograft inflammation and rejection. However, the role of cyclic guanosine …
Reversal of experimental autoimmune diabetes with an sCD39/anti-CD3 treatment
Extracellular (e) ATP, a potent proinflammatory molecule, is released by dying/damaged
cells at the site of inflammation and is degraded by the membrane ectonucleotidases CD39 …
cells at the site of inflammation and is degraded by the membrane ectonucleotidases CD39 …
[HTML][HTML] Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism
R Al-Khalidi, C Panicucci, P Cox, N Chira, J Róg… - Acta Neuropathologica …, 2018 - Springer
Duchenne muscular dystrophy (DMD) is the most common inherited muscle disorder that
causes severe disability and death of young men. This disease is characterized by …
causes severe disability and death of young men. This disease is characterized by …
Increased P2X7 expression in the gastrointestinal tract and skin in a humanised mouse model of graft-versus-host disease
P Cuthbertson, SR Adhikary, NJ Geraghty… - Clinical …, 2020 - portlandpress.com
Background: Allogeneic haematopoietic stem cell transplantation (HSCT) is a curative
therapy for blood cancers; but results in the development of graft-versus-host disease …
therapy for blood cancers; but results in the development of graft-versus-host disease …
[HTML][HTML] The NLRP3 inflammasome regulates corneal allograft rejection through enhanced phosphorylation of STAT3
C Wei, L Ma, H Chi, L Li, S Zhang, W Yin, T Liu… - American Journal of …, 2020 - Elsevier
The success of corneal transplantation is limited by allograft rejection, but the pathogenic
mechanisms of this disease remain poorly defined. In this study, we showed that the NOD …
mechanisms of this disease remain poorly defined. In this study, we showed that the NOD …